GLP-1 vs Contrave for Weight Loss: Which Medication Works Better in 2024?

Sarah spent six months on Contrave and lost 12 pounds. Her friend Jessica started semaglutide around the same time and dropped 35 pounds. Both women ate similar diets and exercised three times weekly. Stories like this play out constantly in weight loss communities, leaving people wondering: what's the real difference between these medications?

The answer isn't just about which drug is "better." It's about understanding two completely different mechanisms of action, different side effect profiles, and dramatically different results in clinical trials. GLP-1 receptor agonists like semaglutide and tirzepatide work through hormonal pathways that regulate blood sugar and appetite. Contrave combines two older generic drugs—naltrexone and bupropion—that affect brain chemistry related to cravings and reward.

Let's break down what the science actually shows, because the differences are bigger than most people realize.

How These Medications Work: Two Completely Different Approaches

Contrave takes a neurological approach to weight loss. It's a combination pill containing naltrexone (an opioid antagonist originally used for addiction) and bupropion (an antidepressant that also reduces appetite). The theory is that these two drugs work together on the hypothalamus and mesolimbic reward system to reduce food cravings and the pleasure response from eating.

You'll take Contrave as pills twice daily, gradually increasing from one pill in the morning to two pills twice daily over the first month. The medication doesn't directly affect your metabolism or how your body processes food. Instead, it's working on your brain's hunger and reward signals.

GLP-1 medications work completely differently. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are injectable medications that mimic naturally occurring hormones in your gut. When you eat, your intestines release GLP-1 hormones that signal fullness, slow stomach emptying, and help regulate blood sugar.

These medications amplify that natural process. You'll feel full faster and stay satisfied longer. Your stomach physically empties more slowly, which isn't just a brain signal—it's an actual physiological change. GLP-1 medications also work directly on areas of the brain that control appetite, but through hormonal pathways rather than neurotransmitter changes.

Tirzepatide goes a step further by also activating GIP receptors, another gut hormone that affects metabolism and fat storage. This dual action is why tirzepatide often shows slightly better results than semaglutide alone.

The practical difference? Contrave tries to make you want food less. GLP-1 medications make you feel genuinely full with less food and keep you satisfied for hours. We see this distinction play out constantly in our patients—it's not just willpower, it's physiology.

What the Clinical Trial Data Actually Shows

When you compare head-to-head clinical trial results, the difference in effectiveness becomes crystal clear. Let's look at the numbers from the major trials.

In the Contrave trials (COR-I and COR-II), participants lost an average of 5-6% of their body weight after one year. That means someone weighing 200 pounds would lose about 10-12 pounds. About 42% of people on Contrave lost at least 5% of their body weight, compared to 17% on placebo. Only 21% lost 10% or more of their starting weight.

Now compare that to GLP-1 results. The STEP 1 trial studied semaglutide 2.4 mg (the Wegovy dose) in adults with obesity. Participants lost an average of 14.9% of their body weight over 68 weeks—that's nearly 30 pounds for someone starting at 200 pounds. More than two-thirds of participants lost at least 10% of their body weight, and nearly one-third lost 20% or more.

The SURMOUNT-1 trial studying tirzepatide showed even more dramatic results. At the highest dose (15 mg), participants lost an average of 20.9% of their body weight. That's 42 pounds for someone starting at 200 pounds. More than half of participants lost at least 20% of their starting weight.

These aren't small differences. We're talking about 2-3 times more weight loss with GLP-1 medications compared to Contrave. In our clinical experience, patients notice this difference quickly—often within the first month.

It's also worth noting that the SELECT trial demonstrated that semaglutide reduces cardiovascular events by 20% in people with existing heart disease. Contrave hasn't shown similar cardiovascular benefits in large-scale trials.

Side Effects: What You'll Actually Experience

Both medications come with side effects, but they're quite different in nature. Understanding what you might experience helps you prepare and decide which medication fits your lifestyle better.

Contrave's most common side effects are neurological and digestive. About 30% of people experience nausea, especially when first starting or increasing the dose. Headaches affect roughly 18% of users. Constipation is common, occurring in about 19% of patients. Many people also report dizziness, insomnia, or dry mouth.

The more concerning issue with Contrave is that it can increase blood pressure and heart rate in some people. Your doctor will need to monitor this regularly. The medication also carries a black box warning about suicidal thoughts and behaviors because it contains bupropion, an antidepressant. If you have a history of seizures, eating disorders, or uncontrolled hypertension, Contrave isn't recommended.

You also can't take Contrave if you're using opioid medications, because the naltrexone component blocks opioid receptors. This becomes a real problem if you need pain management.

GLP-1 medications have a different side effect profile. Nausea is the most common complaint, affecting 40-50% of people at some point, though it usually improves after the first few weeks. Vomiting, diarrhea, and constipation can occur. Most people find that eating smaller meals and avoiding fatty foods minimizes these effects.

The gastrointestinal side effects can be managed by starting at a low dose and increasing slowly. In our experience, patients who rush the dose escalation have much worse nausea than those who go slowly and listen to their bodies.

GLP-1 medications don't typically raise blood pressure—they often lower it slightly, which is actually beneficial. They don't cause the sleep issues or mood changes that sometimes occur with Contrave. The main contraindication is a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Cost, Convenience, and Insurance Coverage

This is where things get complicated, and it's often what determines which medication people can actually access.

Contrave is available as a generic (naltrexone/bupropion), which makes it significantly cheaper than brand-name GLP-1 medications. Generic Contrave typically costs $80-150 per month without insurance. Many insurance plans cover it because it's been around since 2014 and uses two older, well-established medications.

Brand-name GLP-1 medications are expensive. Wegovy and Zepbound can cost $1,000-1,400 per month without insurance. Insurance coverage is improving but still inconsistent. Many plans exclude weight loss medications entirely or require extensive prior authorization proving you've tried other methods first.

That's where compounded versions become relevant. Compounded semaglutide and tirzepatide offer the same active ingredients at a fraction of the cost—often $99-299 per month through telehealth providers. These aren't the brand-name products, but they contain the same medication prepared by licensed compounding pharmacies.

Convenience-wise, Contrave requires taking pills twice daily, every day. You'll need to remember your morning and evening doses. GLP-1 medications are injected once weekly. Many people find the weekly injection more convenient than remembering pills twice daily, even though needles sound more intimidating at first.

The injections use very small needles (similar to what diabetics use for insulin), and most patients tell us they barely feel them after the first few times. You'll inject subcutaneously—into the fatty tissue of your abdomen, thigh, or upper arm.

What Women Should Know

Women need to consider a few specific factors when choosing between these medications. If there's any possibility of pregnancy, GLP-1 medications aren't recommended. You should stop them at least two months before trying to conceive. Contrave is also not recommended during pregnancy, so both medications require reliable birth control if you're sexually active and could become pregnant.

Some women find that Contrave affects their menstrual cycle, particularly if they're sensitive to bupropion. Mood changes can be more pronounced in women with a history of depression or anxiety. On the flip side, the neurological approach of Contrave might help with emotional eating patterns that women report more frequently than men.

GLP-1 medications may actually improve polycystic ovary syndrome (PCOS) symptoms in some women. Weight loss itself often helps regulate cycles, and there's emerging research suggesting GLP-1 medications might have direct benefits for insulin resistance associated with PCOS.

What Men Should Know

Men often respond well to both medications, but there are some specific considerations. If you use opioid pain medications for any reason—whether for chronic pain, recovery from surgery, or other conditions—Contrave is off the table. The naltrexone component will block opioid receptors and could trigger withdrawal if you're using opioids.

Blood pressure monitoring becomes especially important for men on Contrave, as men are at higher baseline risk for hypertension. The medication can increase both blood pressure and heart rate, which needs careful monitoring if you already have cardiovascular risk factors.

In our clinical experience, men often prefer the simplicity of weekly GLP-1 injections over remembering pills twice daily. The more dramatic weight loss results with GLP-1 medications also tend to improve testosterone levels in men with obesity, which can have additional benefits for energy, mood, and metabolic health.

From the Ozari Care Team

We recommend starting with realistic expectations regardless of which medication you choose. Contrave can be effective for people who struggle primarily with cravings and emotional eating, but you'll need to pair it with consistent lifestyle changes to see meaningful results. If you're looking for more substantial weight loss and have significant obesity, GLP-1 medications typically deliver better outcomes based on what we see clinically and what the research shows. Don't let fear of injections hold you back—most of our patients are surprised by how easy the weekly shots become, and the results usually outweigh any initial hesitation.

Key Takeaways

• GLP-1 medications produce 2-3 times more weight loss than Contrave in clinical trials—averaging 15-21% body weight loss versus 5-6% with Contrave over one year
• Contrave works on brain chemistry to reduce cravings; GLP-1 medications work through gut hormones to create genuine fullness and slow digestion—fundamentally different mechanisms
• Contrave costs less as a generic ($80-150/month) and has better insurance coverage, while brand-name GLP-1s are expensive but available as compounded versions for $99-299/month
• Contrave requires twice-daily pills and can raise blood pressure; GLP-1s are weekly injections with primarily digestive side effects that usually improve over time
• If you can't take opioids or have a history of seizures/eating disorders, Contrave isn't an option; GLP-1s are contraindicated mainly for those with specific thyroid cancer histories

Frequently Asked Questions

Can I take Contrave and a GLP-1 medication together?

There's no specific drug interaction that prevents combining these medications, but doctors rarely prescribe them together because there's no research showing added benefit and you'd be dealing with side effects from both. If Contrave isn't working well enough, most physicians will switch you to a GLP-1 rather than adding it on top. That said, some patients do use Contrave for its effects on food cravings while on a lower GLP-1 dose, but this should only be done under close medical supervision.

How long does it take to see results with each medication?

With Contrave, you'll typically see gradual weight loss starting around week 4-8, once you've reached the full dose. Most people lose about 5 pounds in the first month if it's working for them. GLP-1 medications often show faster initial results—many people notice decreased appetite within days and lose 5-10 pounds in the first month, with continued steady loss over the following months. The weight loss with GLP-1s tends to continue for 12-18 months before plateauing, while Contrave reaches its maximum effect around 6 months.

What happens when you stop taking these medications?

With both medications, there's a risk of weight regain when you stop. Contrave doesn't typically cause rebound weight gain beyond what you'd expect from losing the medication's appetite-suppressing effects. GLP-1 medications can lead to more noticeable weight regain because they create such significant changes in hunger hormones—when you stop, your appetite often returns to baseline or even increases temporarily. The STEP 1 trial extension showed that people regained about two-thirds of their lost weight within a year of stopping semaglutide. This is why many doctors now view these as long-term medications rather than short-term fixes.

Which medication is safer for long-term use?

Both have been studied for long-term use, though GLP-1 medications like semaglutide have more extensive long-term safety data because they've been used for diabetes management since 2017. The SELECT trial followed semaglutide users for over three years and actually found cardiovascular benefits. Contrave has been available since 2014 with a reasonable safety profile, but the bupropion component means ongoing monitoring for mood changes and the naltrexone means you can't use opioid pain medications. Neither medication has shown serious long-term safety concerns in most people, but GLP-1s have the added benefit of improving metabolic markers beyond just weight loss.

Will insurance cover these medications or do I have to pay out of pocket?

Insurance coverage varies dramatically by plan. Contrave has better coverage overall because it's available as a generic and has been around longer, but many plans still exclude weight loss medications entirely or classify them as "cosmetic." GLP-1 medications are more likely to be covered if you have diabetes or prediabetes, but coverage for weight loss alone is still inconsistent despite FDA approval. You'll typically need a BMI over 30 (or over 27 with weight-related health conditions) and documentation of previous weight loss attempts. If insurance won't cover them, compounded versions of GLP-1 medications have made them much more accessible at $99-299 per month compared to $1,000+ for brand names.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.